Abstract: A myopia-inhibiting treatment device produces a therapeutic light that includes components of different wavelengths in a ratio of luminosities that creates a predetermined L-cone to S-cone excitation profile that slows ocular growth, thereby mitigating development of myopia. The components comprise blue light, green light, and red light. Therapeutic light may cause an L-cone to S-cone excitation ratio in a range between 1.38 and 0.05. In some implementations the therapeutic light causes a L-cone to S-cone excitation ratio of 0.74. In some implementations the luminosity of the combined light components is greater than 700 lux.

Abstract: A myopia-inhibiting treatment device produces a therapeutic light that includes components of different wavelengths in a ratio of luminosities that creates a predetermined L-cone to S-cone excitation profile that slows ocular growth, thereby mitigating development of myopia. The components comprise blue light, green light, and red light. Therapeutic light may cause an L-cone to S-cone excitation ratio in a range between 1.38 and 0.05. In some implementations the therapeutic light causes a L-cone to S-cone excitation ratio of 0.74. In some implementations the luminosity of the combined light components is greater than 700 lux.